Delivery Order SPE2DB20D2014-SPE2DB25FC67F
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30 units, with a ceiling value of $4,624.30. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,163.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made...
- The Defense Logistics Agency awarded a $7,598.76 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Letrozole 2.5 mg on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This non-set-aside, competitively awarded contract has a ceiling value of $1,528.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in quantities of 30, with a firm fixed price contract structure. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,686.35 on August 29, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 2, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.30 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) valued at $1,081.74. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a pediatric continuation under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award involved no set-aside...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC67FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $1,136.20. This firm fixed price delivery order, which is set to conclude on August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This award is issued through AmerisourceBergen's existing $999.9 billion IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a competitively awarded, non-set-aside contract, this delivery order reflects AmerisourceBergen's ongoing role as a critical pharmaceutical vendor for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract demonstrates the company's continued capability to fulfill federal medical supply requirements, including specialty medications and generic pharmaceuticals across multiple therapeutic domains supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/6/25 |